Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR
Monday, June 1, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA shares another warning about Impella heart pumps after death

The FDA is once again warning the public about a safety issue with certain Impella heart pumps. 

READ MORE >
Impella CP Johnson & Johnson MedTech Abiomed
Share on Twitter Share on Facebook Share on Linkedin

FDA shares another warning about Impella heart pumps after death

Share on Twitter Share on Facebook Share on Linkedin
Impella CP Johnson & Johnson MedTech Abiomed
The FDA is once again warning the public about a safety issue with certain Impella heart pumps. 
READ MORE >

Scrapped CGM sensors stolen, sold to patients—Dexcom pledges to hold thieves accountable

The devices were set aside to be scrapped before they were stolen. Now, patients could be using them and not even know it.

READ MORE >
The Dexcom G7 Continuous Glucose Monitoring System
Share on Twitter Share on Facebook Share on Linkedin

Scrapped CGM sensors stolen, sold to patients—Dexcom pledges to hold thieves accountable

Share on Twitter Share on Facebook Share on Linkedin
The Dexcom G7 Continuous Glucose Monitoring System
The devices were set aside to be scrapped before they were stolen. Now, patients could be using them and not even know it.
READ MORE >

FDA sees potential in new AI software for monitoring heart failure patients

The software-only platform helps clinicians keep track of patients when they are at their most vulnerable.

READ MORE >
The Cardiac Performance Simulation Engine (CPSE) is an AI platform that enables consumer-grade smartwatches and blood pressure cuffs for remote home monitoring hemodynamic assessments of heart failure patients.
Share on Twitter Share on Facebook Share on Linkedin

FDA sees potential in new AI software for monitoring heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
The Cardiac Performance Simulation Engine (CPSE) is an AI platform that enables consumer-grade smartwatches and blood pressure cuffs for remote home monitoring hemodynamic assessments of heart failure patients.
The software-only platform helps clinicians keep track of patients when they are at their most vulnerable.
READ MORE >

SAPT after TAVR linked to key benefits over DAPT, new data confirm

All-cause mortality after six months was significantly lower for patients discharged on SAPT. That trend remained in place after 24 months.

READ MORE >
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
Share on Twitter Share on Facebook Share on Linkedin

SAPT after TAVR linked to key benefits over DAPT, new data confirm

Share on Twitter Share on Facebook Share on Linkedin
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
All-cause mortality after six months was significantly lower for patients discharged on SAPT. That trend remained in place after 24 months.
READ MORE >

Featured Articles

Have clinicians been wrong about how they diagnose PAD?

The ankle-brachial index, a noninvasive diagnostic test for peripheral artery disease, may provide even more value than clinicians previously realized. 

READ MORE >
leg amputation below the knee
Share on Twitter Share on Facebook Share on Linkedin

Have clinicians been wrong about how they diagnose PAD?

Share on Twitter Share on Facebook Share on Linkedin
leg amputation below the knee
The ankle-brachial index, a noninvasive diagnostic test for peripheral artery disease, may provide even more value than clinicians previously realized. 
READ MORE >

FDA gives greenlight to new AI tool for managing heart failure patients

New AI-enabled software from Cardiosense estimates a patient's PCWP without the use of a catheter or implant. 

READ MORE >
CMS greenlights LDCT lung cancer screening
Share on Twitter Share on Facebook Share on Linkedin

FDA gives greenlight to new AI tool for managing heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
CMS greenlights LDCT lung cancer screening
New AI-enabled software from Cardiosense estimates a patient's PCWP without the use of a catheter or implant. 
READ MORE >

American Heart Association takes on cardiac amyloidosis with new initiative

One of the project's biggest goals is helping clinicians identify patients in need of care earlier than ever.

READ MORE >
Video of Mathew S. Maurer, MD, director, Cardiac Amyloidosis Program, NewYork Presbyterian Hospital, explains how the American Hearty Association’s ATTR Amyloidosis Initiative is bringing together multidisciplinary teams to strengthen management of transthyretin amyloid cardiomyopathy (ATTR-CM). The goal is to catch more of these patients earlier and ensure they get timely care before they end up in advanced heart failure. #ATTR #Cardiacamyloidosis
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association takes on cardiac amyloidosis with new initiative

Share on Twitter Share on Facebook Share on Linkedin
Video of Mathew S. Maurer, MD, director, Cardiac Amyloidosis Program, NewYork Presbyterian Hospital, explains how the American Hearty Association’s ATTR Amyloidosis Initiative is bringing together multidisciplinary teams to strengthen management of transthyretin amyloid cardiomyopathy (ATTR-CM). The goal is to catch more of these patients earlier and ensure they get timely care before they end up in advanced heart failure. #ATTR #Cardiacamyloidosis
One of the project's biggest goals is helping clinicians identify patients in need of care earlier than ever.
READ MORE >

In Case You Missed It

Physician and his practice to pay $6.7M for allegedly performing unnecessary vascular procedures

The physician was accused of pressuring Medicare patients into undergoing treatment they did not need. One patient allegedly received 42 different stents over an eight-year period.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Physician and his practice to pay $6.7M for allegedly performing unnecessary vascular procedures

Share on Twitter Share on Facebook Share on Linkedin
The physician was accused of pressuring Medicare patients into undergoing treatment they did not need. One patient allegedly received 42 different stents over an eight-year period.
READ MORE >

Upfront costs of robotic heart surgery are high—but it may be a smart investment

Makoto Hashimoto, MD, PhD, said robotic procedures are associated with a faster recovery time and many other potential benefits.

READ MORE >
Video of Makoto Hashimoto, MD, PhD, professor and director of robotic cardiac surgery at Florida International University, Baptist Health, who presented a study on robotic surgery outcomes and costs at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. While the costs of these minimally invasive robotic procedures is higher that traditional surgical procedures, he said costs overall can be reduced in terms of faster patient recovery, shorter length of stays.
Share on Twitter Share on Facebook Share on Linkedin

Upfront costs of robotic heart surgery are high—but it may be a smart investment

Share on Twitter Share on Facebook Share on Linkedin
Video of Makoto Hashimoto, MD, PhD, professor and director of robotic cardiac surgery at Florida International University, Baptist Health, who presented a study on robotic surgery outcomes and costs at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. While the costs of these minimally invasive robotic procedures is higher that traditional surgical procedures, he said costs overall can be reduced in terms of faster patient recovery, shorter length of stays.
Makoto Hashimoto, MD, PhD, said robotic procedures are associated with a faster recovery time and many other potential benefits.
READ MORE >

PHOTO GALLERY: Cardiac surgery technologies at the AATS 106th Annual Meeting

A wide variety of technologies, including robotic systems, heart valves, stent grafts, retractors and annuloplasty rings, were on display in Chicago.

READ MORE >
The Abbott Tendyne transcatheter mitral valve replacement system on. display at AATS 2026. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

PHOTO GALLERY: Cardiac surgery technologies at the AATS 106th Annual Meeting

Share on Twitter Share on Facebook Share on Linkedin
The Abbott Tendyne transcatheter mitral valve replacement system on. display at AATS 2026. Photo by Dave Fornell
A wide variety of technologies, including robotic systems, heart valves, stent grafts, retractors and annuloplasty rings, were on display in Chicago.
READ MORE >

In Other News

Primary care as public utility: Imagine that, researchers urge

A team of healthcare scholars is making U.S. states an offer they hope the border-defined polities won’t refuse: If you’ll pay for the reinvention of primary care, we’ll help sell the public on the rightness of measured, state-level efforts to preserve the profession.

READ MORE >
Electric workers
Share on Twitter Share on Facebook Share on Linkedin

Primary care as public utility: Imagine that, researchers urge

Share on Twitter Share on Facebook Share on Linkedin
Electric workers
A team of healthcare scholars is making U.S. states an offer they hope the border-defined polities won’t refuse: If you’ll pay for the reinvention of primary care, we’ll help sell the public on the rightness of measured, state-level efforts to preserve the profession.
READ MORE >

Philips partners with Disney to incorporate iconic characters in MRI exams

The Amsterdam-based imaging manufacturer said it will utilize beloved animated characters and stories as part of the Philips Ambient Experience. 

READ MORE >
Philips Disney ambient experience MRI
Share on Twitter Share on Facebook Share on Linkedin

Philips partners with Disney to incorporate iconic characters in MRI exams

Share on Twitter Share on Facebook Share on Linkedin
Philips Disney ambient experience MRI
The Amsterdam-based imaging manufacturer said it will utilize beloved animated characters and stories as part of the Philips Ambient Experience. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup